Since its establishment, Kelun Pharmaceutical has insisted on investing tens of millions of yuan in independent research and development every year, and has fully mastered the core technology of infusion production. Kelun Pharmaceutical Research Institute was approved as a national postdoctoral research workstation and has applied for dozens of patents. Kelun Pharmaceutical was rated as a "Key High-tech Enterprise in the National Torch Plan"; in January 2008, Sichuan Kelun Pharmaceutical Co., Ltd. It was rated as a "National Innovative Pilot Enterprise" by the Ministry of Science and Technology. In 2005, the "upright soft bag" infusion independently developed by Kelun Pharmaceutical with multiple patented technologies was successfully launched. This product integrates the latest achievements of China's contemporary infusion manufacturing technology and represents the future development direction of China's infusion packaging materials. It is the first of its kind both at home and abroad, and is profoundly changing the landscape of the infusion industry. The "upright soft bag" infusion has great promotion value in ensuring people's medication safety, energy conservation and environmental protection, and has been awarded the title of "High-tech Innovative Product" in Sichuan Province. The product's airdropability played an irreplaceable role in the rescue work of the "5.12" Wenchuan Earthquake. As an "indestructible" infusion product, emergency airdrops were carried out to the disaster area, saving countless lives.
As the world's largest professional manufacturer of infusion products, Kelun Pharmaceutical's infusion products account for more than 20% of the overall domestic market share. It has a large and loyal customer base, and the word-of-mouth spread of hundreds of millions of audiences has made the Kelun brand Solid as a rock. Kelun Pharmaceutical products are also exported in batches and enjoy a high reputation in six major overseas markets, including Southeast Asia and Kazakhstan. Kelun Pharmaceutical has jointly developed the U.S. infusion product market by cooperating with the American company SAGENT, establishing a new milestone in Kelun Pharmaceutical's quality reputation and career heights.
Kelun Pharmaceutical adheres to the corporate purpose of "seeking truth through science and seeking goodness through ethics", and has initially established a primary allocation based on efficiency, a second allocation based on government finance and taxation, and social charity. Awareness of harmonious development of the third career-oriented distribution. Kelun Pharmaceutical has provided tens of millions of RMB in donations to social welfare undertakings, glorious undertakings and needy groups over the years (including 30 million RMB in donations to people in the "5.12" earthquake-stricken areas), which demonstrates Kelun Pharmaceutical's The concept of wealth and quality and the sense of social justice show the healthy development trajectory of an excellent private enterprise under market economy conditions. Especially after the "5.12" Wenchuan earthquake, Kelun Pharmaceutical worked with the people of the country to go all out for earthquake relief. Kelun Pharmaceutical is one of the first companies in China to do its best to donate generously; it is one of the first companies to open land channels for rescue medicines and implement emergency airdrops; it is one of the first companies in China to endure huge pressure in the continuous aftershocks and insist on production to save itself. Enterprise; it is the enterprise that supports the most, including the international medical teams sent to Sichuan for earthquake relief. In the face of national crisis, Kelun Pharmaceutical performed outstandingly. "China Medical News", "Medical Economic News" and other authoritative media have made in-depth reports on Kelun Pharmaceutical's command efficiency, logistical support, professional capabilities and fighting spirit. Chairman Liu Gexin of Kelun Pharmaceutical was also awarded the title of Outstanding Communist Party Member for Earthquake Relief by the Sichuan Provincial Party Committee and the Chengdu Municipal Party Committee, and the honorable title of Sichuan Province Earthquake Relief Model by the Sichuan Provincial Party Committee and the Provincial Government.
Kelen Pharmaceutical will make full use of its nationwide marketing and sales network and leverage the company’s technological advantages, product system advantages, quality advantages, raw material supply advantages and strong R&D capabilities in the infusion industry. Based on the production enterprises, we will continue to adjust and optimize the product structure to further increase the company's market share in the domestic infusion industry; at the same time, we will actively promote the development of non-infusion products, find new scale and profit growth points, and continuously enhance the company's competitive strength. , striving to become one of the pharmaceutical manufacturers with the largest scale, the most comprehensive product specifications, the highest profitability and the strongest competitiveness in China's pharmaceutical industry in 2010.